IP Library Granted Patent US 8,940,526
Granted Patent B2
US 8,940,526 · App. 13/765,249 · Granted Jan 27, 2015

Self-contained biological analysis

Inventors: Kirk M. Ririe (Salt Lake City, UT); Michael R. Newswander (Hyde Park, UT); Randy P. Rasmussen (Salt Lake City, UT); Mark Aaron Poritz (Salt Lake City, UT); Stewart Benjamin Smith (Salt Lake City, UT); David E. Jones (Clearfiedl, UT); Gary Clark Kessler (Bountiful, UT)
Assignee: BioFire Diagnostics, LLC
C12Q1/6844B01L3/50273B01L3/502723B01L7/52B01L2200/10B01L2300/0816B01L2300/0867B01L2300/087B01L2300/1822B01L2400/0478B01L2400/0481B01L2400/049B01L2400/0644B01L2400/065B01L2400/0655B01L2400/0677B01L2400/0683
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,526
App. No.
13/765,249
Granted
Jan 27, 2015
Kind
B2
Abstract

Devices, containers, and methods are provided for performing biological analysis in a closed environment. Illustrative biological analyzes include nucleic acid amplification and detection and immuno-PCR.

Claims (21)

1. A container for performing two-stage nucleic acid amplification on a sample in a closed system comprising

one or more sealable ports, the sealable ports providing the only access from an exterior of the container such that when all of the one or more sealable ports is sealed, the container is fully closed, the one or more sealable ports including a sample injection port for introducing the sample into the container,

a cell lysis zone configured for lysing cells or spores located in the sample, the cell lysis zone fluidly connected to the sample injection port,

a nucleic acid preparation zone fluidly connected to the cell lysis zone, the nucleic acid preparation zone configured for purifying nucleic acids,

a first-stage reaction zone fluidly connected to the nucleic acid preparation zone, the first-stage reaction zone comprising a first-stage reaction blister configured for first-stage amplification of the sample, and

a second-stage reaction zone fluidly connected to the first-stage reaction zone, the second-stage reaction zone comprising a plurality of second-stage reaction chambers, each second-stage reaction chamber comprising a pair of primers configured for further amplification of the sample, the second-stage reaction zone configured for contemporaneous thermal cycling of all of the plurality of second-stage reaction chambers.

2. The container of claim 1 wherein the first-stage amplification is multiplex amplification for a plurality targets, and each pair of primers in the second-stage reaction chambers is configured for further amplification of one of the first-stage targets.

3. The container of claim 2 wherein each pair of primers in the second stage reaction chamber is configured to be nested within primers used in amplifying the first-stage targets.

4. The container of claim 1 wherein the one or more sealable ports further comprise a second port configured to receive water or reagents, and the sealable ports are configured to be sealed subsequent to introduction of the sample and water or reagents and remain sealed through first- and second-stage amplification.

5. The container of claim 1 wherein the cell lysis zone comprises a cell lysis blister containing a plurality of lysing particles.

6. The container of claim 5 wherein the particles are zirconium silicate beads.

7. The container of claim 6 wherein the nucleic acid preparation zone comprises DNA-binding magnetic beads.

8. The container of claim 1 wherein the blister comprises a flexible material, such that pressure provided on the blister collapses the blister, forcing the contents from the blister.

9. The container of claim 8 wherein the flexible material is a flexible plastic film.

10. The container of claim 1 wherein the second-stage reaction zone further comprises one or more additional second-stage reaction chambers, each of the additional second-stage reaction chambers configured as amplification controls.

11. The container of claim 1 wherein the sealable ports are heat sealable.

12. A container for performing two-stage nucleic acid amplification on a sample in a closed system comprising

one or more sealable ports, the sealable ports providing the only access from an exterior of the container such that when all of the one or more sealable ports is sealed, the container is fully closed, the one or more sealable ports including a sample injection port for introducing the sample into the container,

a first-stage reaction zone fluidly connected to the sample injection port, the first-stage reaction zone comprising a first-stage reaction blister configured for first-stage amplification of the sample, and

a second-stage reaction zone fluidly connected to the first-stage reaction zone, the second-stage reaction zone comprising a plurality of second-stage reaction chambers, each second-stage reaction chamber comprising a pair of primers configured for further amplification of the sample, the second-stage reaction zone configured for contemporaneous thermal cycling of all of the plurality of second-stage reaction chambers.

13. The container of claim 12 further comprising a cell lysis zone configured for lysing cells or spores located in the sample, a nucleic acid preparation zone fluidly connected to the cell lysis zone, the nucleic acid preparation zone configured for purifying nucleic acids, the cell lysis zone and the nucleic acid preparation zone both fluidly located between the sample injection port and the first-stage reaction zone.

Assignments (4)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS (RECORDED 3/26/13 AT REEL/FRAME 030091/0893) Recorded Dec 11, 2014
From: ATHYRIUM OPPORTUNITIES FUND (A) LP, AS ADMINISTRATIVE AGENT
To: BIOFIRE DIAGNOSTICS, INC.
Reel/Frame 034609/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2014
From: BIOFIRE DEFENSE, LLC
To: BIOFIRE DIAGNOSTICS, LLC
Reel/Frame 033010/0518 →
CERTIFICATE OF CONVERSION Recorded May 21, 2014
From: BIOFIRE DIAGNOSTICS, INC.
To: BIOFIRE DEFENSE, LLC
Reel/Frame 032981/0888 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 26, 2013
From: BIOFIRE DIAGNOSTICS, INC.
To: ATHYRIUM OPPORTUNITIES FUND (A) LP, AS ADMINISTRATIVE AGENT
Reel/Frame 030091/0893 →
Continuity (3)
Continuation 11913120
Provisional Application 60679052 · May 9, 2005
Related Publication 20130157349A1 · Jun 20, 2013